Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Buzaid

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Clinics in Laboratory Medicine|February 28, 2001
Classification and staging of melanomaJ E Gershenwald, A C Buzaid, M I Ross
Oncology (Williston Park, N.Y.)|November 1, 1995
Systemic treatments for advanced cutaneous melanomaC M Anderson, A C Buzaid, S S Legha
Cancer Treatment and Research|January 1, 1996
Interaction of chemotherapy and biological response modifiers in the treatment of melanomaC M Anderson, A C Buzaid, E A Grimm
The Western Journal of Medicine|February 1, 1989
Managing malignant pericardial effusionA C Buzaid, H S Garewal, B R Greenberg
Hematology/Oncology Clinics of North America|October 6, 1998
Classification and staging of melanomaJ E Gershenwald, A C Buzaid, M I Ross
The American Review of Respiratory Disease|April 1, 1991
Critical analysis of neoadjuvant therapy for Stage IIIa non-small cell lung cancer [corrected]J R Murren, A C Buzaid, W N Hait
The American Journal of Medicine|September 1, 1987
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potentialA C Buzaid, S M Lippman, T P Miller
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines, H Earl, A C Buzaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinomaA C Buzaid, A Robertone, C Kisala, et al.
Cancer|August 1, 1992
Giant cell carcinoma of the lungS S Ginsberg, A C Buzaid, H Stern, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Clinics in Laboratory Medicine|February 28, 2001
Classification and staging of melanomaJ E Gershenwald, A C Buzaid, M I Ross
Oncology (Williston Park, N.Y.)|November 1, 1995
Systemic treatments for advanced cutaneous melanomaC M Anderson, A C Buzaid, S S Legha
Cancer Treatment and Research|January 1, 1996
Interaction of chemotherapy and biological response modifiers in the treatment of melanomaC M Anderson, A C Buzaid, E A Grimm
The Western Journal of Medicine|February 1, 1989
Managing malignant pericardial effusionA C Buzaid, H S Garewal, B R Greenberg
Hematology/Oncology Clinics of North America|October 6, 1998
Classification and staging of melanomaJ E Gershenwald, A C Buzaid, M I Ross
The American Review of Respiratory Disease|April 1, 1991
Critical analysis of neoadjuvant therapy for Stage IIIa non-small cell lung cancer [corrected]J R Murren, A C Buzaid, W N Hait
The American Journal of Medicine|September 1, 1987
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potentialA C Buzaid, S M Lippman, T P Miller
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines, H Earl, A C Buzaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinomaA C Buzaid, A Robertone, C Kisala, et al.
Cancer|August 1, 1992
Giant cell carcinoma of the lungS S Ginsberg, A C Buzaid, H Stern, et al.
Pageof 8